Product Description
Brand Mindray
Sample Type Serum
Pack Size 2 x 50T, 2 x 100T
CAT No 10500421700, 10500424400
Application Immuno-Assay
Ourchemiluminescence immunoassay reagentshave been specially developed to work with Mindrays CL series automatic chemiluminescence immunoassay analyzers to make a complete system, offering high reliability and accuracy. Mindray uses liquid, ready-to-use reagents which come in two packages, 50 tests and 100 tests, to suit customers with different requirements.
Precision in Cancer Marker QuantificationThe Mindray CA 19-9 CLIA Kit is crafted for precise and quantitative measurement of the CA 19-9 antigen, commonly used in monitoring certain cancers. Its advanced chemiluminescence technology ensures exceptional sensitivity and specificity, yielding accurate and reliable results necessary for guiding clinical decisions.
Efficiency and Compatibility for Modern LaboratoriesSupporting a throughput of up to 100 tests per hour, this kit seamlessly integrates with Mindray CLIA analyzers for fully automated, real-time testing. With a calibration stability of 28 days and ready-to-use reagents, the system is ideal for laboratories aiming for efficiency and scalability in cancer diagnostics.
Robust Design and Easy HandlingPackaged in sturdy white reagent boxes, these kits are designed for portability and ease of storage. Each 100-test kit is composed of diagnostic-grade materials and features silent operation. Shelf life is maintained at 12 months when stored at 28C, with no risk of performance loss due to freeze-thaw cycles.
FAQs of MIndray Carbohydrate Antigen 19-9 (CLIA):
Q: How is the Mindray CA 19-9 CLIA reagent kit used in clinical laboratories?
A: This reagent kit is intended for in vitro diagnostic use, specifically for the quantitative detection of carbohydrate antigen 19-9 (CA 19-9) in human serum or plasma. It requires a compatible Mindray CLIA analyzer to automate and display test results.
Q: What is the recommended sample type and volume for testing?
A: The kit is validated for use with human serum or plasma samples. Each test requires a sample volume of 50 L for accurate detection of CA 19-9.
Q: When and where should this diagnostic kit be stored for optimal performance?
A: Store the kit at temperatures between 28C, avoiding freeze-thaw cycles to maintain a shelf life of up to 12 months. It is recommended to store it in a controlled laboratory refrigeration unit.
Q: What is the benefit of the calibration stability feature of this kit?
A: The calibration for the Mindray CA 19-9 CLIA Kit remains stable for up to 28 days, reducing the frequency of recalibration and thereby streamlining workflow and minimizing downtime in busy diagnostic settings.
Q: How does the kit ensure high accuracy and reliability in test results?
A: The reagent kit employs chemiluminescence immunoassay (CLIA) technology, which is known for its high sensitivity and specificity, ensuring results align with clinical diagnostic standards.
Q: What is the process for operating this kit in a laboratory setting?
A: After loading the ready-to-use reagents and samples into a compatible Mindray CLIA analyzer, the system runs tests automatically, displaying quantitative CA 19-9 results on the analyzers display. Theres no manual intervention required during actual testing.
Q: What advantages does this kit offer over other cancer marker assays?
A: Besides its high sensitivity, the kit features automated, silent operation, portability, and efficiencydelivering up to 100 tests per hourwhich collectively improve laboratory productivity and reduce turnaround times for cancer marker quantification.